Phytoniosome: a Novel Drug Delivery for Myrtle Extract

Overview

Journal Iran J Pharm Res

Publisher Brieflands

Specialty Pharmacology

Date 2018 Aug 22

PMID 30127807

Citations 14

Authors

Mahboobeh Raeiszadeh

Abbas Pardakhty

Fariba Sharififar

Mehrnaz Mehrabani

Hojjat Nejat-Mehrab-Kermani

Mitra Mehrabani

Affiliations

Soon will be listed here.

Abstract

Traditionally, (myrtle) has been used for treatment of several kinds of disorders. However, there are some factors, namely, low solubility and permeability, which restrict use of myrtle extract (ME) in medical applications. Regarding these limitations, the aim of the present study was to develop a new niosomal formulation to enhance ME stability and permeability. Briefly, several niosomal formulations were prepared by non-ionic surfactants and cholesterol with different molar ratios. Afterward, size, entrapment efficiency (EE%), release and stability of niosomal myrtle extract (nME) were investigated. The effect of ME and nME on viability of 3T3 cells was evaluated using MTT assay. Antibacterial activity of ME and nME was also assessed against , , . Sizes of niosomes were 5.3 ± 0.3 to 15.9 ± 2.2 µm with 4.1 ± 0.3 to 26.9 ± 1.7 mV zeta potential. The EE% of niosomes was varied from 45.4% to 93.4%. An release study on F5 formulation (Span60: Tween60: cholesterol (3:3:4 molar ratio)) revealed that about 36.9%, 38.5% and 26.7% of phytoconstituents were released within 12 h from acetate cellulose membrane, 0.45 µm, regenerated cellulose membrane, 0.45 µm, and cellophane dialysis sack, 12000 Da, respectively. F5 formulation significantly showed lower toxicity on cells. It had higher antibacterial activity that has been shown by lower MICs and higher zone of inhibition compared to ME. Overall, F5 formulation in the presence of 4% ME produced stable multi lamellar vesicles with optimal release and EE%. This formulation also exhibited better antibacterial activity than ME.

Citing Articles

The healing effect of nano emulsified Plantago major L extract on oral wounds in a wistar rat model.

Jahanimoghadam F, Javidan A, Ranjbar M, Torabi M, Kakooei S, Sharififar F BMC Complement Med Ther. 2024; 24(1):327.

PMID: 39227926 PMC: 11370219. DOI: 10.1186/s12906-024-04621-z.

Efficacy of a Combined Herbal Product Containing and in Zoonotic Cutaneous Leishmaniasis Patients Treated along Glucantime ®.

Bozorgzade S, Kalantar-Khandani S, Amiri R, Dehesh T, Karegar-Borzi H Iran J Parasitol. 2024; 19(2):203-213.

PMID: 39011534 PMC: 11246213. DOI: 10.18502/ijpa.v19i2.15856.

Myrtle: a versatile medicinal plant.

Gorjian H, Khaligh N Nutrire. 2024; 48(1):10.

PMID: 38625264 PMC: 9933039. DOI: 10.1186/s41110-023-00194-y.

Effect of L. Plant Extract as a Milk Supplement on the Performance, Selected Blood Parameters and Immune Response of Holstein Calves.

Uyarlar C, Rahman A, Ozcinar U, Cetingul I, Gultepe E, Bayram I Animals (Basel). 2024; 14(5).

PMID: 38473110 PMC: 10930416. DOI: 10.3390/ani14050725.

Antiviral and antimicrobial applications of chalcones and their derivatives: From nature to greener synthesis.

Nematollahi M, Mehrabani M, Hozhabri Y, Mirtajaddini M, Iravani S Heliyon. 2023; 9(10):e20428.

PMID: 37810815 PMC: 10556610. DOI: 10.1016/j.heliyon.2023.e20428.

References

Mahboubi M . Myrtus communis L. and its application in treatment of Recurrent Aphthous Stomatitis. J Ethnopharmacol. 2016; 193:481-489. DOI: 10.1016/j.jep.2016.09.054. View

Hao Y, Li K . Entrapment and release difference resulting from hydrogen bonding interactions in niosome. Int J Pharm. 2010; 403(1-2):245-53. DOI: 10.1016/j.ijpharm.2010.10.027. View

Raeiszadeh M, Pardakhty A, Sharififar F, Farsinejad A, Mehrabani M, Hosseini-Nave H . Development, physicochemical characterization, and antimicrobial evaluation of niosomal myrtle essential oil. Res Pharm Sci. 2018; 13(3):250-261. PMC: 5921405. DOI: 10.4103/1735-5362.228955. View

Hosseini S, Zandi M, Rezaei M, Farahmandghavi F . Two-step method for encapsulation of oregano essential oil in chitosan nanoparticles: preparation, characterization and in vitro release study. Carbohydr Polym. 2013; 95(1):50-6. DOI: 10.1016/j.carbpol.2013.02.031. View

Mokhtar M, Sammour O, Hammad M, Megrab N . Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008; 361(1-2):104-11. DOI: 10.1016/j.ijpharm.2008.05.031. View

Yeh M, Huang H, Liaw J, Huang M, Huang K, Hsu F . Dermal delivery by niosomes of black tea extract as a sunscreen agent. Int J Dermatol. 2012; 52(2):239-45. DOI: 10.1111/j.1365-4632.2012.05587.x. View

Jin Y, Wen J, Garg S, Liu D, Zhou Y, Teng L . Development of a novel niosomal system for oral delivery of Ginkgo biloba extract. Int J Nanomedicine. 2013; 8:421-30. PMC: 3559077. DOI: 10.2147/IJN.S37984. View

Aleksic V, Knezevic P . Antimicrobial and antioxidative activity of extracts and essential oils of Myrtus communis L. Microbiol Res. 2013; 169(4):240-54. DOI: 10.1016/j.micres.2013.10.003. View

Ajazuddin , Saraf S . Applications of novel drug delivery system for herbal formulations. Fitoterapia. 2010; 81(7):680-9. DOI: 10.1016/j.fitote.2010.05.001. View

10.

Guinedi A, Mortada N, Mansour S, Hathout R . Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 2005; 306(1-2):71-82. DOI: 10.1016/j.ijpharm.2005.09.023. View

11.

Gerbeth K, Husch J, Meins J, Rossi A, Sautebin L, Wiechmann K . Myrtucommulone from Myrtus communis: metabolism, permeability, and systemic exposure in rats. Planta Med. 2012; 78(18):1932-8. DOI: 10.1055/s-0032-1327881. View

12.

Junyaprasert V, Teeranachaideekul V, Supaperm T . Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS PharmSciTech. 2008; 9(3):851-9. PMC: 2977041. DOI: 10.1208/s12249-008-9121-1. View

13.

Varshosaz J, Taymouri S, Pardakhty A, Asadi-Shekaari M, Babaee A . Niosomes of ascorbic acid and α-tocopherol in the cerebral ischemia-reperfusion model in male rats. Biomed Res Int. 2014; 2014:816103. PMC: 4163366. DOI: 10.1155/2014/816103. View

14.

Babaee N, Mansourian A, Momen-Heravi F, Moghadamnia A, Momen-Beitollahi J . The efficacy of a paste containing Myrtus communis (Myrtle) in the management of recurrent aphthous stomatitis: a randomized controlled trial. Clin Oral Investig. 2009; 14(1):65-70. DOI: 10.1007/s00784-009-0267-3. View

15.

Varshosaz J, Pardakhty A, Hajhashemi V, Najafabadi A . Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv. 2003; 10(4):251-62. DOI: 10.1080/drd_10_4_251. View

16.

Manosroi A, Jantrawut P, Akihisa T, Manosroi W, Manosroi J . In vitro and in vivo skin anti-aging evaluation of gel containing niosomes loaded with a semi-purified fraction containing gallic acid from Terminalia chebula galls. Pharm Biol. 2011; 49(11):1190-203. DOI: 10.3109/13880209.2011.576347. View

17.

Hao Y, Zhao F, Li N, Yang Y, Li K . Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm. 2002; 244(1-2):73-80. DOI: 10.1016/s0378-5173(02)00301-0. View

18.

Mahale N, Thakkar P, Mali R, Walunj D, Chaudhari S . Niosomes: novel sustained release nonionic stable vesicular systems--an overview. Adv Colloid Interface Sci. 2012; 183-184:46-54. DOI: 10.1016/j.cis.2012.08.002. View

19.

Di Marzio L, Marianecci C, Petrone M, Rinaldi F, Carafa M . Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20. Colloids Surf B Biointerfaces. 2010; 82(1):18-24. DOI: 10.1016/j.colsurfb.2010.08.004. View

20.

Hoh C, Boocock D, Marczylo T, Singh R, Berry D, Dennison A . Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences. Clin Cancer Res. 2006; 12(9):2944-50. DOI: 10.1158/1078-0432.CCR-05-2724. View